Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Health
Tara Cosoleto

DARK SECRETS: First vaccine approved for infectious respiratory virus | Vintage Vibes

The TGA has approved a respiratory syncytial virus vaccine for Australians aged 60 and over. (Joel Carrett/AAP PHOTOS)

A vaccine to combat a highly infectious respiratory disease has been approved for use in Australia for the first time. 

The Therapeutic Goods Administration has ticked off AREXVY to be used as a respiratory syncytial virus vaccine for Australians aged 60 and over. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.